Post-Transcriptional Regulation of Lung Fibrosis.

肺纤维化的转录后调控。

基本信息

  • 批准号:
    10734543
  • 负责人:
  • 金额:
    $ 55.72万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-05 至 2028-05-31
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY/ABSTRACT Idiopathic pulmonary fibrosis (IPF) is a fatal progressive fibrotic disease characterized with excessively deposited extracellular matrix (ECM) proteins. Persistent myofibroblast activation is considered as one of driving forces that lead to excessive ECM protein production and fibrosis in IPF. The molecular mechanisms that perpetuate persistent myofibroblast activation and pro-fibrotic responses in IPF have not been fully understood. KH-Type Splicing Regulatory Protein (KSRP) is a mRNA destabilizing protein involved in post-transcriptional regulation of gene expression. Preliminary data demonstrate that KSRP expression is significantly decreased in IPF lung fibroblasts and tissues when compared to that in normal human lung fibroblasts and tissues. However, the role of KSRP in lung fibrosis, and the functional consequences of pathologic KSRP downregulation in pro-fibrotic responses in IPF, are completely unknown. This proposal aims to reveal the novel restrictive role of KSRP in lung fibrosis and the molecular mechanisms involved. Preliminary data demonstrate that KSRP deficient mice have increased lung fibrosis when compared to wild-type mice in response to Bleomycin, and that KSRP deficiency promotes, while gain of KSRP inhibits, myofibroblast differentiation and ECM protein production. These data indicate that KSRP functions as a restricting factor of fibrotic reactions, and impaired KSRP function promotes fibrotic reactions and lung fibrosis. Furthermore, KSRP negatively regulates Migfilin mRNA stability and expression and KSRP deficiency results in increased Migfilin expression. Our preliminary data demonstrate that Migfilin functions as a “pro-fibrotic switch”, promoting pro-fibrotic reactions. Migfilin is required for myofibroblast differentiation and survival. Based on preliminary data, we hypothesize that KSRP functions as a restrictive regulator of lung fibrosis, and that impaired KSRP function fosters a “pro-fibrotic niche” fueling persistent myofibroblast differentiation and pro-fibrotic responses mediated by Migfilin and Migfilin mediated signaling. To test the hypothesis, three specific AIMs are proposed. Specific AIM 1 will determine the mechanisms by which KSRP regulates myofibroblast differentiation and survival. Specific AIM 2 will determine the restrictive role of KSRP in controlling ECM expression and matrix assembly. Specific AIM 3 will examine the in vivo cell-specific role of KSRP in fibrogenesis and functional consequences. The findings will help to understand the mechanisms that perpetuate persistent myofibroblast activation and pro-fibrotic responses in IPF and serve my long-term goal to develop effective therapy for IPF.
项目摘要/摘要 特发性肺纤维化(IPF)是一种致死性进行性纤维化疾病,其特征在于过度沉积的 细胞外基质(ECM)蛋白。持续的肌成纤维细胞活化被认为是驱动力之一 导致IPF中ECM蛋白过度产生和纤维化。使人类得以延续的分子机制 IPF中持续的肌成纤维细胞活化和促纤维化反应尚未完全了解。KH型 剪接调节蛋白(KSRP)是一种mRNA去稳定蛋白,参与转录后调控, 基因表达。初步数据表明,KSRP表达在IPF肺中显著降低, 与正常人肺成纤维细胞和组织相比,然而,作用 KSRP在肺纤维化中的作用,以及在促纤维化中病理性KSRP下调的功能后果。 IPF的缓解情况完全未知。该提案旨在揭示KSRP在以下方面的新颖限制作用 肺纤维化及其分子机制。初步数据表明,KSRP缺陷小鼠 与野生型小鼠相比,对博莱霉素的反应增加了肺纤维化, KSRP缺乏促进肌成纤维细胞分化和ECM蛋白产生,而KSRP获得抑制肌成纤维细胞分化和ECM蛋白产生。 这些数据表明,KSRP作为纤维化反应的限制因素发挥作用, 促进纤维化反应和肺纤维化。此外,KSRP负调节Migfilin mRNA的稳定性 表达和KSRP缺陷导致Migfilin表达增加。我们的初步数据显示 Migfilin作为“促纤维化开关”发挥作用,促进促纤维化反应。以下情况需要Migfilin 肌成纤维细胞分化和存活。根据初步数据,我们假设KSRP的功能是 肺纤维化的限制性调节因子,并且受损的KSRP功能促进了“促纤维化生态位”, 持续的肌成纤维细胞分化和促纤维化反应介导的Migfilin和Migfilin介导的 信号为了检验这一假设,提出了三个具体的目标。特定的AIM 1将决定 KSRP调节肌成纤维细胞分化和存活的机制。特定的AIM 2将决定 KSRP在控制ECM表达和基质组装中的限制性作用。具体目标3将检查 KSRP在纤维发生和功能后果中体内细胞特异性作用。这些发现将有助于 了解IPF中持续存在肌成纤维细胞活化和促纤维化反应的机制 并服务于我的长期目标,即开发有效的IPF治疗方法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Pulin Che其他文献

Pulin Che的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Epalrestat, an aldose reductase inhibitor, alleviates bleomycin-induced skin fibrosis in mice : drug repositioning study for human systemic sclerosis
依帕司他(一种醛糖还原酶抑制剂)可减轻博来霉素诱导的小鼠皮肤纤维化:人类系统性硬化症的药物重新定位研究
  • 批准号:
    20K17346
  • 财政年份:
    2020
  • 资助金额:
    $ 55.72万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Therapy for melanoma with the combination of bleomycin and immune checkpoint inhibitors
博来霉素和免疫检查点抑制剂联合治疗黑色素瘤
  • 批准号:
    19K08760
  • 财政年份:
    2019
  • 资助金额:
    $ 55.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Thrombomodulin suppresses bleomycin-induced pulmonary fibrosis and develop to a new candidate for IPF treatment
血栓调节蛋白可抑制博莱霉素诱导的肺纤维化,成为 IPF 治疗的新候选药物
  • 批准号:
    19K08844
  • 财政年份:
    2019
  • 资助金额:
    $ 55.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A role of FcgRIIB in the development of murine bleomycin-induced fibrosis model
FcgRIIB 在小鼠博莱霉素诱导的纤维化模型发展中的作用
  • 批准号:
    19K17766
  • 财政年份:
    2019
  • 资助金额:
    $ 55.72万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The role of vascular endothelial growth factor receptor 1 tyrosine kinase signaling in bleomycin-induced pulmonary fibrosis
血管内皮生长因子受体1酪氨酸激酶信号在博莱霉素诱导的肺纤维化中的作用
  • 批准号:
    19K09291
  • 财政年份:
    2019
  • 资助金额:
    $ 55.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The role of alveolar epithelial type I cells in bleomycin-induced lung injury: Characterization of fibrosis-relevant signal pathways
I 型肺泡上皮细胞在博来霉素诱导的肺损伤中的作用:纤维化相关信号通路的表征
  • 批准号:
    373703964
  • 财政年份:
    2017
  • 资助金额:
    $ 55.72万
  • 项目类别:
    Research Grants
Anti-inflammatory and anti-fibrotic effects of intravenous adipose-derived stem cell transplantation in a mouse model of bleomycin-induced scleroderma
静脉脂肪干细胞移植对博来霉素诱导的硬皮病小鼠模型的抗炎和抗纤维化作用
  • 批准号:
    17K16216
  • 财政年份:
    2017
  • 资助金额:
    $ 55.72万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Changes in pulmonary endothelial cell and fibroblast properties during bleomycin-induced pulmonary fibrosis
博来霉素诱导肺纤维化过程中肺内皮细胞和成纤维细胞特性的变化
  • 批准号:
    17K09609
  • 财政年份:
    2017
  • 资助金额:
    $ 55.72万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Statin-polymer nanoparticles enhance the anti-inflammatory and anti-fibrotic effects of adipose-derived stem cell transplantation in a mouse model of bleomycin-induced scleroderma
他汀类聚合物纳米粒子增强博莱霉素诱导的硬皮病小鼠模型中脂肪干细胞移植的抗炎和抗纤维化作用
  • 批准号:
    17K15761
  • 财政年份:
    2017
  • 资助金额:
    $ 55.72万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Effect of function-blocking RHAMM peptides on adipogenesis in a bleomycin-induced scleroderma mouse model
功能阻断 RHAMM 肽对博莱霉素诱导的硬皮病小鼠模型脂肪生成的影响
  • 批准号:
    367375
  • 财政年份:
    2016
  • 资助金额:
    $ 55.72万
  • 项目类别:
    Studentship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了